drugset

drugset / Trial / NCT03950843

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

NCT03950843 ↗

Phase 3 Unknown 162 enrolled Chong Kun Dang Pharmaceutical

RandomizedParallel-groupDouble-blindTreatment

Summary

to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

Timeline

Start: 2019-04-23
Primary completion: 2021-09
Completion: 2021-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-825	Unknown	—	—

Indications